凱帆藥劑國際股票討論區

declare 3.6 cents special dividend .... shareholders huat !
not bad div track record; hope profit will improve post-Covid environment ....
Hyphens Pharma Dividend Yield (1J5)

$凱帆藥劑國際(1J5.SG)$ "We're thrilled to be featured in SAC Capital Private Limited's video, as one of the investment gems ....."
Hyphens Pharma International Ltd. on LinkedIn: Uncovering Gems Listed on SGX series - Hyphens Pharma International…

$凱帆藥劑國際(1J5.SG)$
Phillip Capital Research Report  09 Mar 2023
Assembling multiple growth engines

$凱帆藥劑國際(1J5.SG)$Hyphens Pharma reports two times surge in 2HFY2022 earnings of $5.2 mil  
".... FY2022 earnings per share (EPS) stood at 3.66 cents on a diluted basis and on the group’s continuing operations. As at Dec 31, 2022, cash and cash equivalents stood at $36.5 million. A first and final dividend of 1.11 cents has been proposed for the period, up from FY2021’s dividend of 0.67 cents...."

$凱帆藥劑國際(1J5.SG)$ watching 👀, trying to BO from 1 year pivot. Thinly traded counter though.

$凱帆藥劑國際(1J5.SG)$ showed solid growth the last few quarters after their last acquisition, with 4% dividend and potential for more growth with their digital arm, albeit a bit slow.

$凱帆藥劑國際(1J5.SG)$ Hyphens Pharma International Ltd (SGX: 1J5) – is a specialty pharmaceutical and consumer healthcare company with a diversified ASEAN footprint. It markets and sells a range of specialty pharmaceutical products in key ASEAN countries through exclusive distributorship or licensing agreements with brand principals mainly from Europe and United States. It also develops, markets, and sells its own...